Guidelines Insights: Hepatobiliary Cancers, Version 2.2019

Al B. Benson, Michael I. D'Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Daniel Brown, Daniel T. Chang, Jordan Cloyd, Anne M. Covey (+19 others)
2019 The Journal of the National Comprehensive Cancer Network  
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and updated recommendations regarding systemic therapy for first-line
more » ... nd subsequent-line treatment of patients with hepatocellular carcinoma.
doi:10.6004/jnccn.2019.0019 pmid:30959462 fatcat:655pzpuprjd5jguyvouetgjclu